The Importance of Your Care Team

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Despite the initial shock and challenges, I found strength and support within the community of single parents.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

I've learned that cooking for friends during their cancer journey is a way to express love and support, even if it doesn't cure them.

CURE® spoke with experts about what life is like for patients with cancer when their disease is in remission.